Form 4 for SNDX Syndax Pharmaceuticals Inc
Accepted 2023-02-08 00:00:00 ET · period of report 2023-02-06 · accession 0001562180-23-001117 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-02-08 | 2023-02-06 | SNDX | Morrison Briggs | Pres, Head of R, D, Dir | M - OptEx | $6.38 | +52.9K | 70.7K | +296% | +$337.2K |
| D | 2023-02-08 | 2023-02-06 | SNDX | Morrison Briggs | Pres, Head of R, D, Dir | S - Sale+OE | $26.83 | -52.9K | 17.8K | -75% | -$1.42M |
| D | 2023-02-08 | 2023-02-06 | SNDX | Morrison Briggs | Pres, Head of R, D, Dir | M - OptEx | $0.00 | -52.9K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-06 | M | A | 52,854 | $6.38 | 70,690 | D | — | — | |
| 2 | Common | Common Stock | 2023-02-06 | S | D | 52,854 | $26.83 | 17,836 | D | — | — | (F2) The sale prices ranged from $26.49 to $27.91. |
| 3 | Derivative | Stock Options (Right to buy) | 2023-02-06 | M | D | 52,854 | $0.00 | 0 | D | $6.38 · — to 2029-02-06 | 52,854 Common Stock | (F3) This option is fully vested. |